# Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study

> **NCT04656899** · NA · COMPLETED · sponsor: **Washington State University** · enrollment: 41 (actual)

## Conditions studied

- Opioid-use Disorder

## Interventions

- **BEHAVIORAL:** Reminders messages to improve adherence.

## Key facts

- **NCT ID:** NCT04656899
- **Lead sponsor:** Washington State University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-06
- **Primary completion:** 2021-10-11
- **Final completion:** 2021-10-11
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2023-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04656899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04656899, "Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04656899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*